Sun Pharma

Sun Pharma will present seven LEQSELVI presentations at the EADV Congress 2026, including long-term safety and efficacy data in…

Lerodalcibep is approved in the EU under the brand name Lyrokaul for the treatment of adult patients with hypercholesterolaemia…

The company will offer MFN pricing to state Medicaid programmes and for future innovative medicines under the agreement with the…

Sun Pharmaceutical Industries announced that it has received approval from the Brazilian Health Regulatory Agency, ANVISA to…

Sun Pharmaceutical Industries announced that the stockholders of Organon have approved the proposals in connection with the…

Company to launch once-weekly injectable for adults with type 2 diabetes in the South African market

Sun Pharma’s $12 billion acquisition of Organon will prove to be a milestone as the largest takeover by an Indian pharma company.…

While we agree that “what got us here (an affordable generics powerhouse) will not get us there (a leader in pharma innovation)”,…

Sun Pharma announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a…

Sun Pharma announced UNLOXCYT (cosibelimab-ipdl) is now available in the US for healthcare professionals to  prescribe for adults…